European Medicines Agency Selects Aetion to Support Safety and Efficacy Research in Europe
Aetion has been selected by the European Medicines Agency to support the agency’s Quality, Efficacy, and Safety Studies on Medicines. Aetion is a health care analytics company, working to provide real-world evidence for regulators, manufacturers, and purchasers of medical treatments and technologies. The company was founded by Harvard Medical School faculty members and uses its Evidence Platform® to analyze data and produce honest scientific answers about value, safety, and efficacy. Aetion will perform pharmacoepidemiologic research for the European Medicines Agency and generate real-world-evidence to aid...